全文获取类型
收费全文 | 2237082篇 |
免费 | 156458篇 |
国内免费 | 5372篇 |
专业分类
耳鼻咽喉 | 30122篇 |
儿科学 | 72703篇 |
妇产科学 | 60506篇 |
基础医学 | 323322篇 |
口腔科学 | 61868篇 |
临床医学 | 209088篇 |
内科学 | 425625篇 |
皮肤病学 | 47409篇 |
神经病学 | 179294篇 |
特种医学 | 84571篇 |
外国民族医学 | 564篇 |
外科学 | 323246篇 |
综合类 | 47365篇 |
现状与发展 | 2篇 |
一般理论 | 714篇 |
预防医学 | 176376篇 |
眼科学 | 50391篇 |
药学 | 171108篇 |
12篇 | |
中国医学 | 5532篇 |
肿瘤学 | 129094篇 |
出版年
2019年 | 17764篇 |
2018年 | 25296篇 |
2017年 | 19400篇 |
2016年 | 21411篇 |
2015年 | 24141篇 |
2014年 | 33281篇 |
2013年 | 50345篇 |
2012年 | 69145篇 |
2011年 | 73373篇 |
2010年 | 42914篇 |
2009年 | 39710篇 |
2008年 | 67509篇 |
2007年 | 71889篇 |
2006年 | 72333篇 |
2005年 | 69420篇 |
2004年 | 66310篇 |
2003年 | 63479篇 |
2002年 | 61388篇 |
2001年 | 108962篇 |
2000年 | 111963篇 |
1999年 | 93786篇 |
1998年 | 25232篇 |
1997年 | 22512篇 |
1996年 | 22218篇 |
1995年 | 21038篇 |
1994年 | 19450篇 |
1993年 | 18249篇 |
1992年 | 72672篇 |
1991年 | 70584篇 |
1990年 | 68970篇 |
1989年 | 65828篇 |
1988年 | 60338篇 |
1987年 | 59029篇 |
1986年 | 55906篇 |
1985年 | 53014篇 |
1984年 | 39218篇 |
1983年 | 33280篇 |
1982年 | 19233篇 |
1979年 | 35473篇 |
1978年 | 24604篇 |
1977年 | 20963篇 |
1976年 | 19521篇 |
1975年 | 20917篇 |
1974年 | 25053篇 |
1973年 | 24424篇 |
1972年 | 22854篇 |
1971年 | 21354篇 |
1970年 | 19747篇 |
1969年 | 18483篇 |
1968年 | 17133篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
101.
102.
103.
104.
p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens 总被引:3,自引:0,他引:3
Primary chemotherapy administered to breast cancer patientsis the best model to identify baseline features able to predictwhich patients may be most likely to benefit or not from a cytotoxicregimen. In the March issue of Annals of Oncology two papersevaluated the predictive role of immunohistochemical p53 expressionon 相似文献
105.
106.
107.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
108.
109.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
110.